Palvella Therapeutics, Inc (PVLA) — Cash Flow Quality Index
Palvella Therapeutics, Inc (PVLA) has a Cash Flow Quality Index of -0.73x as of December 2023. Operating cash flow of $-13.70 Million is below net income of $18.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Palvella Therapeutics, Inc asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Palvella Therapeutics, Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Palvella Therapeutics, Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Palvella Therapeutics, Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Palvella Therapeutics, Inc (2023–2023)
Year-by-year earnings quality comparison for Palvella Therapeutics, Inc. For live market cap and the full company financial profile, see how much is Palvella Therapeutics, Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.73x | $-13.70 Million | $18.69 Million | — |